These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27049022)

  • 21. Bladder cancer.
    Grayson M
    Nature; 2017 Nov; 551(7679):S33. PubMed ID: 29117156
    [No Abstract]   [Full Text] [Related]  

  • 22. Bladder cancer: Present and future.
    Martinez Rodriguez RH; Buisan Rueda O; Ibarz L
    Med Clin (Barc); 2017 Nov; 149(10):449-455. PubMed ID: 28736063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder Cancer: A Review.
    Lenis AT; Lec PM; Chamie K; Mshs MD
    JAMA; 2020 Nov; 324(19):1980-1991. PubMed ID: 33201207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China.
    Liu X; Yu C; Bi Y; Zhang ZJ
    Public Health; 2019 Jul; 172():70-80. PubMed ID: 31220754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer and prostatic diseases Best of China, 2018.
    Ye DW; Zhu Y
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):1-2. PubMed ID: 30518869
    [No Abstract]   [Full Text] [Related]  

  • 26. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder Cancer Survivorship.
    Bhanvadia SK
    Curr Urol Rep; 2018 Nov; 19(12):111. PubMed ID: 30414013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of Bladder Cancer.
    Saginala K; Barsouk A; Aluru JS; Rawla P; Padala SA; Barsouk A
    Med Sci (Basel); 2020 Mar; 8(1):. PubMed ID: 32183076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.
    Cumberbatch MGK; Jubber I; Black PC; Esperto F; Figueroa JD; Kamat AM; Kiemeney L; Lotan Y; Pang K; Silverman DT; Znaor A; Catto JWF
    Eur Urol; 2018 Dec; 74(6):784-795. PubMed ID: 30268659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Subtypes of Bladder Cancer.
    McConkey DJ; Choi W
    Curr Oncol Rep; 2018 Aug; 20(10):77. PubMed ID: 30128829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bladder Cancer: Diagnosis and Treatment.
    DeGeorge KC; Holt HR; Hodges SC
    Am Fam Physician; 2017 Oct; 96(8):507-514. PubMed ID: 29094888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of urothelial carcinoma.
    Miyazaki J; Nishiyama H
    Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancer incidence and mortality of kidney and unspecified urinary organs in China, 2015].
    Chen Q; Zheng RS; Zhang SK; Zhang SW; Liu SZ; Sun XB; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1001-1006. PubMed ID: 33342155
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer statistics, 2019.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2019 Jan; 69(1):7-34. PubMed ID: 30620402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical Recurrence After Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes.
    Wu J; Xu PH; Luo WJ; Dai B; Shen YJ; Ye DW; Wang YC; Zhu YP
    Front Surg; 2021; 8():590448. PubMed ID: 33693025
    [No Abstract]   [Full Text] [Related]  

  • 36. Secular Trend of Cancer Death and Incidence in 29 Cancer Groups in China, 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.
    Liu X; Zhou M; Wang F; Mubarik S; Wang Y; Meng R; Shi F; Wen H; Yu C
    Cancer Manag Res; 2020; 12():6221-6238. PubMed ID: 32801868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of muscle-invasive and advanced bladder cancer in 2020.
    Patel VG; Oh WK; Galsky MD
    CA Cancer J Clin; 2020 Sep; 70(5):404-423. PubMed ID: 32767764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The global burden of urinary bladder cancer: an update.
    Richters A; Aben KKH; Kiemeney LALM
    World J Urol; 2020 Aug; 38(8):1895-1904. PubMed ID: 31676912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Renal Cell Carcinoma.
    Capitanio U; Bensalah K; Bex A; Boorjian SA; Bray F; Coleman J; Gore JL; Sun M; Wood C; Russo P
    Eur Urol; 2019 Jan; 75(1):74-84. PubMed ID: 30243799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.